Matches in Wikidata for { <http://www.wikidata.org/entity/Q91868509> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q91868509 description "article scientifique publié en 2020" @default.
- Q91868509 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91868509 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91868509 description "scientific article published on 09 April 2020" @default.
- Q91868509 description "wetenschappelijk artikel" @default.
- Q91868509 description "наукова стаття, опублікована 9 квітня 2020" @default.
- Q91868509 name "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 name "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 type Item @default.
- Q91868509 label "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 label "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 prefLabel "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 prefLabel "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 P1433 Q91868509-61575C3C-CDCD-4FC9-B2C6-DB85514AFE95 @default.
- Q91868509 P1476 Q91868509-3D1D7F69-6293-4614-AB29-8D8BF21E59EA @default.
- Q91868509 P2093 Q91868509-4B475B5F-9F8D-4B99-B71C-59EE37BBD46C @default.
- Q91868509 P2093 Q91868509-7E062CC1-EC26-446D-83FC-0530E4695C99 @default.
- Q91868509 P2093 Q91868509-99BB9601-6D6E-4F3B-A446-F9B4CEDA0EE0 @default.
- Q91868509 P2093 Q91868509-A40D2C1B-3E59-4295-8632-9252B77319E3 @default.
- Q91868509 P2093 Q91868509-A53043CF-52A3-4450-8976-94BDC7A96458 @default.
- Q91868509 P2093 Q91868509-BFF17AFF-8B38-43C9-9CE6-48288DBC5913 @default.
- Q91868509 P2093 Q91868509-D73A7238-FF02-4DB1-8C55-DC6FF2609EC3 @default.
- Q91868509 P2093 Q91868509-E1BA7B69-846F-4E9A-84AA-331650CB29A8 @default.
- Q91868509 P2093 Q91868509-ED44B6CC-9563-456F-ACF4-A5C0D8D380BB @default.
- Q91868509 P275 Q91868509-bc632be3-53f5-4c9a-8c6f-bd2d3e706bdc @default.
- Q91868509 P31 Q91868509-6F7C7B16-160E-4820-BA41-97F14CF5BDE1 @default.
- Q91868509 P356 Q91868509-9A485D48-B9AC-4EBE-840B-EBD51D77282D @default.
- Q91868509 P433 Q91868509-1CC24FB5-7FEB-4A8A-BDA5-D67AABB819AC @default.
- Q91868509 P478 Q91868509-64C6D0A6-83BF-4994-97A4-8EF15706D29E @default.
- Q91868509 P50 Q91868509-0E23C556-0784-4831-BA7B-5400E35D0844 @default.
- Q91868509 P50 Q91868509-4A0C784C-0090-4F7A-9922-EE3361547A67 @default.
- Q91868509 P50 Q91868509-7B4A7234-88B5-4056-AC9B-8C8A38AEF760 @default.
- Q91868509 P577 Q91868509-BA23FE94-8DA9-402F-B342-2A6204F6C895 @default.
- Q91868509 P6216 Q91868509-68425303-4cda-45ea-a888-b2bcfbe029e8 @default.
- Q91868509 P698 Q91868509-2C13B574-6D9F-472F-8AE1-918368834AE7 @default.
- Q91868509 P921 Q91868509-0C796941-1EC3-4267-A6C8-8F8AA3EE7AC7 @default.
- Q91868509 P921 Q91868509-1B2CAB1C-FA29-4BB5-8873-F90924FE24A6 @default.
- Q91868509 P932 Q91868509-AA41DF2F-3CBA-43CD-86A0-27231053B197 @default.
- Q91868509 P356 JCM9041067 @default.
- Q91868509 P698 32283731 @default.
- Q91868509 P1433 Q27724774 @default.
- Q91868509 P1476 "Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study" @default.
- Q91868509 P2093 "Arne Dietrich" @default.
- Q91868509 P2093 "Charlotte Kloft" @default.
- Q91868509 P2093 "David Petroff" @default.
- Q91868509 P2093 "Felix Girrbach" @default.
- Q91868509 P2093 "Frieder Kees" @default.
- Q91868509 P2093 "Hermann Wrigge" @default.
- Q91868509 P2093 "Lisa Ehmann" @default.
- Q91868509 P2093 "Markus Zeitlinger" @default.
- Q91868509 P2093 "Sophie Hochstädt" @default.
- Q91868509 P275 Q20007257 @default.
- Q91868509 P31 Q13442814 @default.
- Q91868509 P356 "10.3390/JCM9041067" @default.
- Q91868509 P433 "4" @default.
- Q91868509 P478 "9" @default.
- Q91868509 P50 Q89961182 @default.
- Q91868509 P50 Q91868501 @default.
- Q91868509 P50 Q91868504 @default.
- Q91868509 P577 "2020-04-09T00:00:00Z" @default.
- Q91868509 P6216 Q50423863 @default.
- Q91868509 P698 "32283731" @default.
- Q91868509 P921 Q323936 @default.
- Q91868509 P921 Q411377 @default.
- Q91868509 P932 "7230366" @default.